3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Liver Failure
1
Hepatitis C
1
Hepatitis B
1
Hepatic Insufficiency
1
HIV Infections
1
Carcinoma, Hepatocellular
1
Interventions
Oxaliplatin
30
Capecitabine
26
Fluorouracil
20
Irinotecan
19
tislelizumab
18
apatinib
16
Paclitaxel
13
Cisplatin
13
S 1 (combination)
12
Radiotherapy
12
Leucovorin
11
Bevacizumab
11
Laparoscopy
9
Drug Therapy
9
Cetuximab
9
sintilimab
8
Endoscopic Mucosal Resection
8
Gemcitabine
7
Docetaxel
7
camrelizumab
6
XELOX
6
Surgical Procedures, Operative
6
Radiation
6
Propranolol
6
Nivolumab
6
Neoadjuvant Therapy
6
Immune Checkpoint Inhibitors
6
Folfox protocol
6
Levoleucovorin
5
HMPL-013
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Raltegravir Potassium
×
Gastrointestinal
×
Clear all
NCT01022476
2026-04-06
LIVERAL
ANRS, Emerging Infectious Diseases
Phase 1/2
Completed
14 enrolled